Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anixa Biosciences Inc Director's Dealing 2016

Feb 19, 2016

34117_dirs_2016-02-19_aeeed52e-3411-4761-a4ba-391b61771fb3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ITUS Corp (ITUS)
CIK: 0000715446
Period of Report: 2016-02-18

Reporting Person: JOHNSON BRUCE F (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-02-18 Employee Stock Options (Right to Buy) $2.92 A 12000 Acquired 2026-02-18 Common Stock (12000) Direct

Footnotes

F1: Right-To-Buy, pursuant to the ITUS Corporation 2010 Share Incentive Plan.

F2: The option vests in four (4) equal installments on each March 31, 2016, June 30, 2016, September 30, 2016 and December 31, 2016.